1. Home
  2. PSTV vs SPPL Comparison

PSTV vs SPPL Comparison

Compare PSTV & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • SPPL
  • Stock Information
  • Founded
  • PSTV 1996
  • SPPL 2016
  • Country
  • PSTV United States
  • SPPL Singapore
  • Employees
  • PSTV N/A
  • SPPL N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • SPPL
  • Sector
  • PSTV Health Care
  • SPPL
  • Exchange
  • PSTV Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • PSTV 10.4M
  • SPPL 9.8M
  • IPO Year
  • PSTV N/A
  • SPPL 2023
  • Fundamental
  • Price
  • PSTV $0.35
  • SPPL $3.25
  • Analyst Decision
  • PSTV Strong Buy
  • SPPL
  • Analyst Count
  • PSTV 3
  • SPPL 0
  • Target Price
  • PSTV $10.83
  • SPPL N/A
  • AVG Volume (30 Days)
  • PSTV 65.4M
  • SPPL 24.1K
  • Earning Date
  • PSTV 08-13-2025
  • SPPL 01-01-0001
  • Dividend Yield
  • PSTV N/A
  • SPPL N/A
  • EPS Growth
  • PSTV N/A
  • SPPL N/A
  • EPS
  • PSTV N/A
  • SPPL N/A
  • Revenue
  • PSTV $5,206,000.00
  • SPPL $2,764,846.00
  • Revenue This Year
  • PSTV $14.10
  • SPPL N/A
  • Revenue Next Year
  • PSTV $7.96
  • SPPL N/A
  • P/E Ratio
  • PSTV N/A
  • SPPL N/A
  • Revenue Growth
  • PSTV N/A
  • SPPL N/A
  • 52 Week Low
  • PSTV $0.16
  • SPPL $2.02
  • 52 Week High
  • PSTV $2.31
  • SPPL $16.80
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 51.85
  • SPPL 59.41
  • Support Level
  • PSTV $0.27
  • SPPL $2.61
  • Resistance Level
  • PSTV $0.37
  • SPPL $2.80
  • Average True Range (ATR)
  • PSTV 0.05
  • SPPL 0.26
  • MACD
  • PSTV 0.02
  • SPPL 0.09
  • Stochastic Oscillator
  • PSTV 67.04
  • SPPL 66.97

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: